Literature DB >> 1107570

Adriamycin-a review.

S K Carter.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1107570     DOI: 10.1093/jnci/55.6.1265

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  93 in total

1.  Cytotoxic properties of iron-hydroxynaphthoquinone complexes in rat hepatocytes.

Authors:  A Kumbhar; S Padhye; D Ross
Journal:  Biometals       Date:  1996-07       Impact factor: 2.949

2.  Sphinganine potentiation of cellular differentiation induced by various anti-leukemia drugs in human leukemia cell line HL-60.

Authors:  B Y Yung
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-11       Impact factor: 3.000

Review 3.  Cancer, chemotherapy and anaesthesia.

Authors:  F Chung
Journal:  Can Anaesth Soc J       Date:  1982-07

4.  ABH antigenicity of in situ carcinoma of the urinary bladder during intracavity treatment with doxorubicin hydrochloride.

Authors:  G Jakse; F Hofstädter
Journal:  Urol Res       Date:  1981

5.  A simplified method for determination of daunorubicin, adriamycin, and their chief fluorescent metabolites in human plasma by high-pressure liquid chromatography.

Authors:  W Bolanowska; T Gessner; H Preisler
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

6.  Ultrastructural features of Adriamycin-induced skeletal and cardiac muscle toxicity.

Authors:  J H Doroshow; C Tallent; J E Schechter
Journal:  Am J Pathol       Date:  1985-02       Impact factor: 4.307

7.  Repeated daunomycin administration in rats. Pharmacokinetics and bone marrow toxicity.

Authors:  K Nooter; P Sonneveld; J Deurloo; R Oostrum; F Schultz; A Martens; A Hagenbeek
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

8.  CCNU-adriamycin association induces earlier and more severe nephropathy in rats.

Authors:  G Raguenez-Viotte; M Lahoue; T Ducastelle; J P Morin; J P Fillastre
Journal:  Arch Toxicol       Date:  1988       Impact factor: 5.153

9.  Elevation of serum lipid peroxide level associated with doxorubicin toxicity and its amelioration by [dl]-alpha-tocopheryl acetate or coenzyme Q10 in mouse (doxorubicin, toxicity, lipid peroxide, tocopherol, coenzyme Q10).

Authors:  N Yamanaka; T Kato; K Nishida; T Fujikawa; M Fukushima; K Ota
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

10.  Distribution and metabolism of rubidazone and daunorubicin in mice.

Authors:  R Baurain; D Deprez-De Campeneere; A Trouet
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.